Single Technologies Company
%20.jpg)
Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become a leading provider of sequencing technologies for the 21st century diagnostics.
Last Funding Type:
Corporate Round
Funding Status:
Seed
Headquarters:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2012-01-01
Investor Type:
For Profit
Total Funding:
$4.9M
Technology:
P4 Medicine
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investors Number:
1
Industry:
Biotechnology, Health Care, Science and Engineering